Evidence map›Paper›PMID 34425842›Full record

ReviewPediatric rheumatology online journal2021

Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches.

Lina N Zaripova, Angela Midgley, Stephen E Christmas, Michael W Beresford, Eileen M Baildam, Rachel A Oldershaw

3 registry-linked trialsAbstract readReview
In one paragraph

Review in Pediatric rheumatology online journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 149 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05837247 nacompletednot on this mapstarted 2023, after this paper: background citation

Effects of Telemonitoring-supported Game-based Home Exercises on Kinesiophobia, Pain and Quality of Life in Juvenile Idiopathic Arthritis

TypeinterventionalSponsorIstanbul University - CerrahpasaRan2023 to 2024Enrolled20ConditionsExercise Therapy, Juvenile Idiopathic ArthritisArmsGame-based telerehabilitation exercises, Home exercises
NCT05871086 phase2 / phase3unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effect of Coenzyme Q10 Supplementation on the Clinical Outcome of Juvenile Idiopathic Arthritis Patients

TypeinterventionalSponsorNourhan ElsherifRan2023 to 2023Enrolled60ConditionsJuvenile Idiopathic ArthritisArmsCoenzyme Q10, Placebo, Standard Regimen
NCT06413563 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Analysis of Peripheral Blood Lymphocytes in Patients With Juvenile Idiopathic Arthritis With Respect to Disease Subtypes and Therapy

TypeobservationalSponsorSohag UniversityRan2024 to 2026Enrolled75ConditionsJuvenile Idiopathic ArthritisArmsComplete blood count
3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lina N ZaripovaDepartment of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, William Henry Duncan Building, 6 West Derby Street, Liverpool, L7 8TX, UK.ORCID https://orcid.org/0000-0001-8728-0225
Angela MidgleyDepartment of Women and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, University Department, Liverpool Women's Hospital, First Floor, Crown Street, Liverpool, L8 7SS, UK.
Stephen E ChristmasDepartment of Clinical Infection, Microbiology and Immunology, Faculty of Health and Life Sciences, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK.
Michael W BeresfordDepartment of Women and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, University Department, Liverpool Women's Hospital, First Floor, Crown Street, Liverpool, L8 7SS, UK.
Eileen M BaildamDepartment of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, East Prescott Road, Liverpool, L14 5AB, UK.
Rachel A OldershawDepartment of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, William Henry Duncan Building, 6 West Derby Street, Liverpool, L7 8TX, UK. lrao1@liverpool.ac.uk.ORCID http://orcid.org/0000-0001-8478-599X

Funding

Medical Research Council MR/P020941/1Medical Research Council MR/R013926/1Wellcome Trust
6 · The paper itself

Abstract

Juvenile idiopathic arthritis (JIA) is the most common paediatric rheumatological disorder and is classified by subtype according to International League of Associations for Rheumatology criteria. Depending on the number of joints affected, presence of extra-articular manifestations, systemic symptoms, serology and genetic factors, JIA is divided into oligoarticular, polyarticular, systemic, psoriatic, enthesitis-related and undifferentiated arthritis. This review provides an overview of advances in understanding of JIA pathogenesis focusing on aetiology, histopathology, immunological changes associated with disease activity, and best treatment options. Greater understanding of JIA as a collective of complex inflammatory diseases is discussed within the context of therapeutic interventions, including traditional non-biologic and up-to-date biologic disease-modifying anti-rheumatic drugs. Whilst the advent of advanced therapeutics has improved clinical outcomes, a considerable number of patients remain unresponsive to treatment, emphasising the need for further understanding of disease progression and remission to support stratification of patients to treatment pathways.

Indexed as

Antirheumatic AgentsArthritis, JuvenileChildDisease ProgressionHumansMedication Therapy ManagementRisk AssessmentAntirheumatic AgentsAetiology of juvenile idiopathic arthritisDisease-modifying anti-rheumatic drug treatmentJuvenile idiopathic arthritisPathogenesis of juvenile idiopathic arthritis

Identifiers

PMID34425842
PMCPMC8383464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.